Indefinite Delivery Contract SPE2DB24D9249

The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract (IDC) valued up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to fulfill the recurring medical supply needs of military health facilities worldwide.

Under this IDC, the DLA has issued several delivery orders to DMS Pharmaceutical Group for the supply of specific pharmaceutical products, such as lubricants, contraceptive devices like Mirena and Nexplanon, and ophthalmic medications. These delivery orders, valued at $37, $7,104, and $8,576.28 respectively, are not designated as set-aside contracts. Through this contract vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of military personnel and their dependents across various Department of Defense healthcare facilities.